Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:28:56.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The update adds Revision: v3.4.2 and removes the prior government funding/operating status notices; overall study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:06:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and NIH operating status was added, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:42:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI and metadata updates only, no changes to core study content or functionality. The updates include adding a glossary toggle, capitalization tweaks to the update-status label, and a new revision/version indicator.
    Difference
    0.2%
    Check dated 2026-01-28T00:30:28.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 in the page footer; no impact on study details, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:33:57.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section was reorganized: explicit per-state locations (e.g., California, Colorado, Florida, etc.) were removed and replaced with a general 'Locations' heading listing regions, accompanied by a revision tag update from v3.3.2 to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T08:28:46.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.